The Discounted Cash Flow (DCF) valuation of Icure Pharmaceutical Inc (175250.KQ) is 1,094.07 KRW. With the latest stock price at 1,852.00 KRW, the upside of Icure Pharmaceutical Inc based on DCF is -40.9%.
Based on the latest price of 1,852.00 KRW and our DCF valuation, Icure Pharmaceutical Inc (175250.KQ) is a sell. selling 175250.KQ stocks now will result in a potential gain of 40.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.4% | 7.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 666.05 - 1,975.44 | 1,094.07 |
| Upside | -64.0% - 6.7% | -40.9% |